A novel probiotic therapeutic in a murine model of <i>Clostridioides difficile</i> colitis
R Dennis Shelby, Grace E. Janzow, Lauren Mashburn‐Warren, Jeffrey D. Galley, Natalie Tengberg, Jason B. Navarro, Miriam Conces, Michael T. Bailey, Steven D. Goodman, Gail E. Besner
Abstract
first, followed by probiotic administration. Clinical sickness scores (CSS) and intestinal histologic injury scores (HIS) were assigned. . infection when administered as both prophylactic and treatment therapy.
Topics & Concepts
Lactobacillus reuteriProbioticColitisAntibioticsGastroenterologyClindamycinInternal medicineMedicineMicrobiologyLactobacillusOral administrationBiologyBacteriaGeneticsClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disordersGut microbiota and health